| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Kawakami Y | |
| Robbins PF | |||
| P433 | issue | 2 | |
| P304 | page(s) | 100-108 | |
| P577 | publication date | 1996-06-01 | |
| P1433 | published in | Keio Journal of Medicine | Q15755860 |
| P1476 | title | Human melanoma antigens recognized by T lymphocytes | |
| P478 | volume | 45 |
| Q45858725 | Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. |
| Q36821069 | CD8 engineered cytotoxic T cells reprogram melanoma tumor environment. |
| Q28710385 | Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells |
| Q58129532 | Predicting T cell recognition of MHC class I restricted neoepitopes |
| Q27680213 | Structure-based design of altered MHC class II-restricted peptide ligands with heterogeneous immunogenicity |
| Q38990679 | The development of dendritic cell vaccine-based immunotherapies for glioblastoma |
| Q34705057 | Type I Interferons are essential for the efficacy of replicase-based DNA vaccines. |
| Q28066228 | Virotherapy: cancer gene therapy at last? |
| Q89942308 | Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals |
| Q26752297 | Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes |
Search more.